Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

NCT06271681 is registered in ClinicalTrials.gov with VA Sierra Nevada Health Care System as lead sponsor.

NCT NCT06271681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06271681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
Lead sponsor
VA Sierra Nevada Health Care System
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
June 1, 2027
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, pneumococcal vaccines